INNOVATIONS SUBMITTED TO THE 2021 CICI FORUM COMPETITION 

The Canada-Israel Cardiovascular Innovation Forum held an innovation competition targeting early and mid-stage companies with projects in either cardiovascular devices or digital heart health. A total of 31 applications were received and 9 were selected to present their innovation at the April 25th CICI Forum Virtual Event. See the list of presenters and applicants below or you may download the list of presenting companies (with summaries of the innovations) or a non-exhaustive list of other innovations submitted to the competition (summaries included).

CANADIAN PRESENTERS

​Applicant: Stephanie Buryk-Iggers

Company: SPARKED

Innovation: Handheld, non-invasive device for early risk detection of cardiovascular disease
(read summary of innovation)
(view video of presentation)

​Applicant: Daniel Gelman

Company: Aufero Medical

Innovation: Device to stabilize contact force during radiofrequency catheter ablation therapy for atrial fibrillation (view summary of innovation

​Applicant: Surath Gomis

Company: Arma Biosciences

Innovation: A handheld device for rapid, continuous remote monitoring of biochemical markers in patients with heart failure (read summary of innovation)

(view video of presentation)

Applicant: Ali Tavallaei

Company: Magellan Biomedical Inc.

Innovation: A novel catheter allowing for accurate localized steering and tracking of endoluminal devices
(view summary of innovation

Applicant: Ryan Tennant

Company: No named company

Innovation: A novel re-entry device for angioplasty of coronary and peripheral chronic total occlusions
(read summary of innovation

(view video of presentation)

 

ISRAELI PRESENTERS

​Applicant: Lihu Avitov

Company: Revamp Medical

Innovation: The Doraya Catheter - a novel temporary intravenous flow regulator
(read summary of innovation

(view video of presentation)

​Applicant: Nitai Hanani

Company: Paragate Medical Ltd.

Innovation: Implantable Peritoneal Ultrafiltration Device (IPUD) for continuous and active fluid decongestion in heart failure patients
(view summary of innovation

​Applicant: Elon Reshef

Company: Invatin Technologies Ltd.

Innovation: A novel continuous stroke prevention device
(read summary of innovation)

(view video of presentation)

Applicant: Ariel Weigler

Company: Cuspa Ltd.

Innovation: Transcatheter artificial cusp for repair of valve insufficiency
(read summary of innovation

(view video of presentation)

CANADIAN APPLICANTS

​Applicant: Sachin Davis

Company: Flora Bioworks

Innovation: A non-invasive diagnostic platform for the identification of atherosclerotic cardiovascular disease via metagenomic sequencing of the gut microbiome
(view summary of innovation

​Applicant: Marko Jovic

Company: Cardian Diagnostics

Innovation: Saliva-based non-invasive monitoring for heart failure patients (view summary of innovation

​Applicant: Haman Mamdouhi

Company: Health-Bridge

Innovation: Health-Bridge: eliminating the language barrier in health care (view summary of innovation)

 

ISRAELI APPLICANTS

​​Applicant: Doron Adler

Company: Sanolla

Innovation: AI Powered Primary Care Diagnostics Solutions
(view summary of innovation

​Applicant: Arie Huber

Company: PRC Cardio Optic Ltd.

Innovation: An innovative Imaging System For Directing Guidewire Crossing in Arterial Chronic Total Occlusion (“CTO”) and Reducing Contrast Reagent Use in Coronary Angiography (view summary of innovation)

Applicant: Jonathan Maron

Company: VenoVision

Innovation: VenoVision Hemodynamic Remote Monitoring Platform (view summary of innovation

ATTEND THE 2022 CICI FORUM EVENT

On May 15, 2022 at 12 pm EDT (7 pm IDT), the top rated projects from Israel and Canada will present their pitch. Investors interested in cardiovascular innovations are invited to attend the virtual event and to contact the companies of interest after the presentation. There will be breakout rooms for interested parties to connect with the presenters.

The Keynote Speaker for the May 15th event is Peter J. Fitzgerald, MD, PhD, Professor Emeritus Medicine & Engineering at Stanford University Medical Center; Co-founder and Managing partner at  Triventures.